ctrl K

AI Score

Unlock

Kymera Therapeutics Inc. (KYMR)

AI Score

Unlock

26.38

1.14 (4.54%)

At close: Apr 02, 2025, 3:59 PM

26.06

-1.21%

After-hours: Apr 02, 2025, 05:07 PM EDT

Kymera Therapeutics Income Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	47.07M	78.59M	46.83M	72.83M	34.03M	2.93M	n/a
Cost of Revenue	n/a	189.08M	2.98M	2.4M	62.1M	825K	205K
Gross Profit	47.07M	-110.49M	43.85M	70.44M	-28.07M	2.11M	-205K
Operating Income	-261.63M	-165.53M	-161.26M	-100.53M	-46.3M	-42.2M	-21.45M
Interest Income	38.03M	18.76M	6.62M	488K	826K	1M	n/a
Pretax Income	-223.86M	-146.96M	-154.81M	-100.22M	-45.59M	-41.25M	-21.47M
Net Income	-223.86M	-146.96M	-151.83M	-98M	-43.95M	-41.29M	-21.47M
Selling & General & Admin	63.53M	55.04M	43.83M	36.34M	18.23M	7.98M	3.77M
Research & Development	240.25M	189.08M	164.25M	137.02M	62.1M	37.16M	17.68M
Other Expenses	4.92M	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	308.71M	244.12M	208.08M	173.36M	80.34M	45.14M	21.45M
Interest Expense	249K	196K	176K	175K	115K	46K	16K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	308.71M	244.12M	208.08M	173.36M	80.34M	45.14M	21.45M
Income Tax	n/a	n/a	-2.98M	-2.22M	-1.65M	46K	43.86K
Shares Outstanding (Basic)	75.04M	58.37M	53.93M	47.99M	17.35M	44.53M	44.53M
Shares Outstanding (Diluted)	75.04M	58.37M	53.93M	47.99M	17.35M	44.53M	44.53M
EPS (Basic)	-2.98	-2.52	-2.82	-2.04	-2.53	-0.93	-0.48
EPS (Diluted)	-2.98	-2.52	-2.82	-2.04	-2.53	-0.93	-0.48
EBITDA	-216.24M	-143.2M	-151.66M	-97.64M	-43.72M	-40.38M	-21.25M
EBIT	-223.61M	-146.77M	-154.63M	-100.04M	-45.48M	-41.2M	-21.45M
Depreciation & Amortization	7.37M	3.56M	2.98M	2.4M	1.76M	825K	205K